Veijer, Clazinus http://orcid.org/0009-0000-9785-945X
van Hulst, Marinus H. http://orcid.org/0000-0003-3216-7246
Friedrichson, Benjamin http://orcid.org/0000-0003-3790-281X
Postma, Maarten J. http://orcid.org/0000-0002-6306-3653
van Asselt, Antoinette D.I. http://orcid.org/0000-0001-7705-9906
Funding for this research was provided by:
HORIZON EUROPE Health (101045956 — COVend — HORIZON-HLTH-2021-CORONA-01 - 11/11/2021)
Article History
Accepted: 12 March 2024
First Online: 10 May 2024
Declarations
:
: This study was funded by the COVend project (101045956 — COVend — HORIZON-HLTH-2021-CORONA-01 - 11/11/2021).
: Clazinus Veijer, Marinus H. van Hulst, Benjamin Friedrichson, and Antoinette D.I. van Asselt have no conflicts of interest to declare. Maarten J. Postma reports grants and honoraria from various pharmaceutical companies, inclusive those potentially interested in the subject matter of this paper.
: Search strategies, search protocol and reviewing process details are provided as a .docx file in the supplementary material.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: C.V. and ADIvA designed and performed the review and analysed the data. C.V. wrote the manuscript in consultation with A.D.I.v.A. A.D.I.v.A., M.H. and M.P. supervised the project. A.D.I.v.A., M.H., B.F. and M.P. provided critical comments on the manuscript. All authors read and approved the final version.